Immune Biosolutions inc. Email Format
Biotechnology ResearchQuebec, Canada11-50 Employees
Immune Biosolutions is a clinical-stage biotechnology company based in Sherbrooke, Quebec, focused on discovering and engineering antibodies for therapeutic use. It works with avian and human antibody formats to develop custom immunotherapies aimed at complex protein targets. The company combines discovery capabilities with antibody production to advance its own programs in cancer and autoimmune diseases into the early stages of clinical development. In the market, it serves pharmaceutical and biotechnology developers seeking novel antibody-based therapies. In July 2024, the company appointed Nicholas Franco as Chairman of the Board, marking a notable leadership change.